TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
| Website: | www.tgtherapeutics.com |
| Email: | ir@tgtxinc.com |
| Main Phone: | +1 212 554-4484 |
| Address: | 3 Columbus Circle |
| Address 2: | 15th Floor |
| State: | NY |
| City / Town: | New York |
| Country: | USA |
| Postal Code: | 10019 |
| Exchange: | NSC |
| Employees: | 40 |
| NAICS: | Pharmaceutical P |
| Last Price 11.95 | Change $ -0.05 | Change % -0.42 | Tick N/A |
| Bid 11.55 | Bid Size 1,000.00 | Ask 12.20 | Ask Size 400.00 |
| Open 12.00 | High 12.20 | Low 11.55 | Prev Close 12.00 |
| Last Trade | Volume 2 mi | 52 Wk Hi 15.35 | 52 Wk Low 4.10 |
| Market Cap 798 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 66,775,146.00 | EPS (TTM) -1.84 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 7 | 12 |
| Number of Buys | 6 | 9 |
| Number of Sells | 1 | 3 |
| Net Activity | 24328 | 7437324 |
| Last 10 Buys | Shares |
|---|---|
| Michael S. Weiss | 1,000 |
| Neil Herskowitz | 1,000 |
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| Michael S. Weiss | 1,000 |
| Michael S. Weiss | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| William J. Kennedy | 1,000 |
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| Sean A. Power | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 33 | 33 | 33 | 33 |
| Low Target Price Estimate | 15 | 15 | 18 | 15 |
| Mean Target Price Estimate | 24 | 24 | 25.14 | 24 |
| Standard Deviation | 6.98 | 6.98 | 5.37 | 6.98 |
| Date of Most Recent Estimate | 08/11/16 | 08/09/16 | 06/30/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 94 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2016-06-14 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
